NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI)

Historical Holders from Q3 2015 to Q3 2025

Symbol
HFXI
Type / Class
Equity / NYLI FTSE INTERN
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
27,141,107
Holdings value
$841,870,184
% of all portfolios
0%
Number of holders
79
Number of buys
41
Number of sells
-34
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 27,141,107 $841,870,184 +$6,868,461 $31.01 79
2025 Q2 26,750,690 $788,444,661 -$47,372,253 $29.47 80
2025 Q1 28,561,319 $786,070,487 +$122,540,125 $27.52 79
2024 Q4 25,675,549 $671,379,185 +$54,196,434 $26.06 74
2024 Q3 23,085,359 $636,509,940 +$143,821,476 $27.64 68
2024 Q2 18,000,361 $481,076,773 +$20,514,436 $26.7 67
2024 Q1 17,006,586 $456,208,352 +$23,244,404 $26.83 60
2023 Q4 16,152,226 $401,694,395 +$31,890,583 $24.87 57
2023 Q3 14,607,188 $337,996,972 +$42,880,700 $23.14 44
2023 Q2 12,879,982 $308,651,604 +$28,481,711 $23.96 43
2023 Q1 11,698,046 $269,870,888 +$2,432,506 $23.07 34
2022 Q4 11,541,196 $246,407,208 +$35,925,434 $21.35 32
2022 Q3 9,846,147 $189,724,000 +$6,253,948 $19.27 32
2022 Q2 9,497,217 $198,310,000 -$24,185,818 $20.88 33
2022 Q1 10,638,311 $250,991,000 -$12,681,878 $23.6 35
2021 Q4 11,131,755 $278,852,000 -$4,886,562 $25.05 34
2021 Q3 11,327,386 $276,735,240 +$4,223,105 $24.43 37
2021 Q2 11,156,130 $276,323,000 -$806,984 $24.77 30
2021 Q1 11,194,885 $267,555,000 -$5,597,018 $23.9 30
2020 Q4 11,416,347 $258,956,000 -$7,618,599 $22.68 30
2020 Q3 11,752,833 $233,772,000 +$4,833,875 $19.89 27
2020 Q2 11,499,288 $222,585,000 -$29,098,365 $19.36 31
2020 Q1 13,072,121 $219,652,000 +$38,570,181 $16.8 34
2019 Q4 10,756,491 $225,753,000 +$50,889,720 $21.72 38
2019 Q3 8,346,247 $169,761,000 -$78,114,785 $20.34 29
2019 Q2 12,196,288 $248,285,000 -$46,910,718 $20.36 27
2019 Q1 14,500,543 $290,142,000 -$63,179,863 $20.01 23
2018 Q4 17,703,737 $321,639,000 -$103,828,516 $18.17 24
2018 Q3 23,408,214 $493,443,000 -$51,508,384 $21.08 21
2018 Q2 25,852,679 $540,570,000 -$467,770,207 $20.91 20
2018 Q1 48,070,485 $1,011,886,000 +$632,113,688 $21.05 24
2017 Q4 18,041,088 $390,605,000 +$89,856,034 $21.65 21
2017 Q3 13,909,107 $289,033,000 -$10,531,124 $20.78 18
2017 Q2 14,416,171 $290,349,000 +$91,205,550 $20.14 15
2017 Q1 9,888,099 $190,949,000 +$2,806,298 $19.31 14
2016 Q4 8,421,959 $152,687,000 -$136,310 $18.13 10
2016 Q3 8,429,418 $153,669,000 +$25,496,017 $18.23 10
2016 Q2 7,031,646 $120,670,000 +$58,890,784 $17.16 11
2016 Q1 3,582,639 $62,271,000 +$4,656,014 $17.38 9
2015 Q4 3,312,694 $60,228,000 +$25,997,449 $18.18 8
2015 Q3 1,882,697 $33,076,000 +$33,076,000 $17.56 5